For all questions and bookings, please call our reception on (03) 9077 9912
We're available Monday To Friday 08:00am - 06:00pm AEST

Select Language English Chinese (Simplified)

COVID-19 Vaccine at CBD Doctors Melbourne

Update 12 April 2021

CBD Doctors Melbourne has received the first delivery of the COVID-19 vaccine to be administered to patients that qualify for part 1b of rollout.

Unfortunately, this coincides with the announcement by Department of Health in relation to AstraZeneca COVID-19 vaccine on 8 April 2021. The information which is summarised below can be found at https://www.health.gov.au/news/atagi-statement-on-astrazeneca-vaccine-in-response-to-new-vaccine-safety-concerns

There is still a huge benefit in receiving the vaccine for preventing the symptomatic infection with SARS-2 COVID-19.

Please read the latest news about COVID-19 vaccine (AstraZeneca):

Due to the potential link to rare but serious side effect (thrombosis with thrombocytopenia syndrome “TTS”) associated with the AstraZeneca vaccine, Australian Technical and Advisory Group on Immunisation (ATAGI) has issued statement summarised as follows:

TTS remains an extremely rare event among vaccine recipients. Experience in Europe has shown approximately  4–6 people in every one million people develop TTS in the 4-20 days after the first dose of vaccine. However higher rates have been reported in some countries, and among younger people. One person in Australia developed the syndrome after receiving the AstraZeneca vaccine.

  • While Australia currently has very low or no community transmission of COVID-19, this could change. The risk of serious disease and death in Australia remains, even as border controls and other measures continue.
  • The individual benefit-to-risk balance of vaccination with COVID-19 vaccine AstraZeneca in Australia varies with age. The risk of ongoing health issues and death from COVID-19 is highest in older age groups, particularly rising from 50 years of age. By comparison, the rate, and so possibility of disability and death from TTS may be higher in younger people.

 Please note that ATAGI has further recommended that:

  • The AstraZeneca vaccine should only be used in adults aged under 50 where the benefits clearly outweigh the risk for that individual and the person has made an informed decision based on an understanding of the risks and benefits.
  • People who have had the first dose of COVID-19 Vaccine AstraZeneca without any serious adverse effects can be given the second dose, including adults under 50 years.
  • The risk of developing this side-effect following receipt of the AstraZeneca vaccine is extremely rare;
  • The new age-based recommendations are made out of an abundance of caution and the benefits of the COVID-19 AstraZeneca vaccination outweigh the risks for the vast majority of people; and
  • That if you have received your first dose of the vaccine with no major adverse reaction, you are strongly encouraged to receive the second dose as planned.”

Summary of changes:

  1. There is a link between AstraZeneca COVID-19 vaccine and rare but serious condition (TTS).
  2. AstraZeneca vaccine is safe and can be given to people over 50.
  3. Pfizer vaccine is a preferred option for people under 50.
  4. AstraZeneca vaccine should be given to people under 50 with caution, with informed consent, when the benefits of receiving the vaccine overweight risks.
  5. People that have already had one dose of AstraZeneca vaccine are safe to have another dose as scheduled.

Other useful links:

 

************************************************************************************************************************

Updated 29 March 2021

Useful links regarding the AstraZeneca vaccine and your privacy information:

************************************************************************************************************************

The Australian Government has announced that the vaccination phase 1b is ready to commence.How does that work for the CBD Doctors Melbourne? We are ready to commence providing our patients with the vaccine.Our first delivery of the AstraZeneca vaccine is expected mid April.

There will be a small number of vials delivered weekly which has been determined by the Government.

We are hopeful that the vaccine will be manufactured in Melbourne by then and the number of vials available for Australians is going to be sufficient to deliver the vaccine quickly.

The first group to be vaccinated will be people over 70 years of age, Aboriginal and Torres Strait Islanders people older than 55 years of age, younger adults with a disability, chronic conditions, critical and high risk workers.

A process will be in place to prove a patient’s eligibility.

We will update this site regularly.

Please refer to the below two documents early:

If you are not a patient currently registered with the CBD Doctors Melbourne but think you will come to us to receive your vaccine, we suggest that you register as a patient through our website:  https://www.cbddoctorsmelbourne.com.au/

Check your COVID-19 Vaccine eligibility here: https://covid-vaccine.healthdirect.gov.au/eligibility 

Other useful links:

 

Dr Jelena Radosavljevic, MBBS FRACGP

CBD Doctors Melbourne
Level 10,
53 Queen Street
Melbourne 3000
Victoria
Book Appointment